Alexander Leandros Lazarides, MD, discusses research regarding margin assessment in patients with sarcoma.
Alexander Leandros Lazarides, MD
Advertisement
Articles by Alexander Leandros Lazarides, MD
Alexander Leandros Lazarides, MD, resident at Duke University Medical Center, discusses CRM1 as a potential target in osteosarcoma.
Alexander Leandros Lazarides, MD, discusses some of the current challenges in moving the field forward in osteosarcoma.
Advertisement
Latest Updated Articles
Dr. Lazarides on CRM1 as a Potential Target in OsteosarcomaFebruary 21st 2020
Dr. Lazarides on Research Regarding Margin Assessment in SarcomaFebruary 28th 2020
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
The OncFive: Top Oncology Articles for the Week of 5/31
3
From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving
4
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
5